North Derbyshire Health Authority acted unlawfully in denying a patient with multiple sclerosis treatment with interferon beta, a High Court judge ruled last week. The landmark judgment has ramifications for cash-strapped health authorities throughout Britain and will boost the case for a separate NHS fund to pay for expensive new drugs coming on the market as a result of biotechnological advances. Mr Justice Dyson said that the health authority had knowingly imposed what was in effect a blanket ban on the use of the drug, despite guidance in an NHS circular on making it available through hospitals. “A blanket ban was the very antithesis of national policy, …
No takes yet. Share an insight, caveat, or question.
A 1997 study studied this question.